<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00506896</url>
  </required_header>
  <id_info>
    <org_study_id>0599/04</org_study_id>
    <nct_id>NCT00506896</nct_id>
  </id_info>
  <brief_title>Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients</brief_title>
  <official_title>Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients: A Randomized Double-Blind Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy and safety of intra-articular
      glucocorticoid injection to its systemic use for treatment of knee synovitis in patients with
      Rheumatoid Arthritis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized double-blind controlled study was conducted including 60 patients with RA.
      Patients were randomized to receive either a single intra-articular knee injection with
      triamcinolone hexacetonide 60 mg and xylocaine chloride 2% (1 mL) associated to a single
      intramuscular injection of 1 mL of xylocaine chloride 2% (IAI group) or 1 mL of xylocaine
      chloride 2% by intra-articular injection and a intramuscular injection of triamcinolone
      acetonide 60 mg and xylocaine chloride 2% (1 mL) (IM group). Evaluations were performed at
      baseline and 1, 4, 8 and 12 weeks post-intervention. The following instruments were used: the
      ACR 20%, 50 and 70% improvement criteria; VAS for knee morning stiffness, pain and edema;
      knee circumference and goniometry; Likert’s scale of improvement (IVAS); daily use of oral
      glucocorticoid and NSAIDs, blood pressure and adverse effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">January 2006</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS for knee pain</measure>
    <time_frame>12 weeks post intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>side and adverse effects, safety</measure>
    <time_frame>12 weeks post intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intraarticular injection</intervention_name>
    <description>Triamcinolone hexacetonide 60mg(3ml)by intraarticular injection Triamcinolone acetonide 60mg (3ml)by intramuscular administration</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Triancil®</other_name>
    <other_name>Theracort®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Rheumatoid Arthritis diagnosed for more than 6 months

          -  18 and 65 years

          -  Functional class II or III according to the ACR criteria

          -  VAS for knee pain higher than 5

          -  Use of stable doses of oral corticosteroid for the last 30 days

          -  Use of stable doses of DMARDs for the last 3 months

          -  Active synovitis at least in one knee for at least the 30 days

        Exclusion Criteria:

          -  Non-controlled diabetes mellitus or hypertension

          -  Bacterial infection of any site

          -  Blood coagulation disorders

          -  Skin lesion on the affected knee

          -  History of previous surgical procedure in the knee

          -  Use of intra-muscular glucocorticoid in the last 30 days

          -  Intra-articular injection in the last 3 months

          -  Knee injection in the last 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monique S Konai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rita V Furtado, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marla F Santos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jamil Natour, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rheumatology Division, Federal University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04023-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.unifesp.br</url>
    <description>Federal University of Sao Paulo</description>
  </link>
  <reference>
    <citation>Gray RG, Gottlieb NL. Intra-articular corticosteroids. An updated assessment. Clin Orthop Relat Res. 1983 Jul-Aug;(177):235-63. Review.</citation>
    <PMID>6345042</PMID>
  </reference>
  <reference>
    <citation>Verstappen SM, Jacobs JW, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group. The Utrecht experience with different treatment strategies in early rheumatoid arthritis. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S165-8.</citation>
    <PMID>14969070</PMID>
  </reference>
  <reference>
    <citation>See Y. Intra-synovial corticosteroid injections in juvenile chronic arthritis--a review. Ann Acad Med Singapore. 1998 Jan;27(1):105-11. Review.</citation>
    <PMID>9588284</PMID>
  </reference>
  <reference>
    <citation>Caldwell JR. Intra-articular corticosteroids. Guide to selection and indications for use. Drugs. 1996 Oct;52(4):507-14. Review.</citation>
    <PMID>8891463</PMID>
  </reference>
  <reference>
    <citation>Bird HA, Ring EF, Daniel R, Bacon PA. Comparison of intra-articular methotrexate with intra-articular triamcinolone hexacetonide by thermography. Curr Med Res Opin. 1977;5(2):141-6.</citation>
    <PMID>340129</PMID>
  </reference>
  <reference>
    <citation>Marchesoni A, Sinigaglia L, Ranza R, Varenna M, Battafarano N, Tosi S. Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis. Scand J Rheumatol. 1993;22(4):194-8.</citation>
    <PMID>8356413</PMID>
  </reference>
  <reference>
    <citation>Stein A, Yassouridis A, Szopko C, Helmke K, Stein C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain. 1999 Dec;83(3):525-32.</citation>
    <PMID>10568861</PMID>
  </reference>
  <reference>
    <citation>Schatteman L, Gyselbrecht L, De Clercq L, Mielants H. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. J Rheumatol. 2006 Jan;33(1):82-5. Epub 2005 Nov 15.</citation>
    <PMID>16292792</PMID>
  </reference>
  <reference>
    <citation>Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsøe B, Torp-Pedersen S. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis. Scand J Rheumatol. 2006 Sep-Oct;35(5):341-5.</citation>
    <PMID>17062431</PMID>
  </reference>
  <reference>
    <citation>Blyth T, Stirling A, Coote J, Land D, Hunter JA. Injection of the rheumatoid knee: does intra-articular methotrexate or rifampicin add to the benefits of triamcinolone hexacetonide? Br J Rheumatol. 1998 Jul;37(7):770-2.</citation>
    <PMID>9714355</PMID>
  </reference>
  <reference>
    <citation>Hollander JL. Intrasynovial corticosteroid therapy in arthritis. Md State Med J. 1970 Mar;19(3):62-6.</citation>
    <PMID>5441259</PMID>
  </reference>
  <reference>
    <citation>MCCARTY DJ Jr, FAIRES JS. A comparison of the duration of local anti-inflammatory effect of several adrenocorticosteroid esters--a bioassay technique. Curr Ther Res Clin Exp. 1963 May;5:284-90.</citation>
    <PMID>13932060</PMID>
  </reference>
  <reference>
    <citation>Derendorf H, Möllmann H, Grüner A, Haack D, Gyselby G. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther. 1986 Mar;39(3):313-7.</citation>
    <PMID>3948470</PMID>
  </reference>
  <reference>
    <citation>Bain LS, Balch HW, Wetherly JM, Yeadon A. Intraarticular triamcinolone hexacetonide: double-blind comparison with methylprednisolone. Br J Clin Pract. 1972 Dec;26(12):559-61.</citation>
    <PMID>4567862</PMID>
  </reference>
  <reference>
    <citation>Bird HA, Ring EF, Bacon PA. A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Ann Rheum Dis. 1979 Feb;38(1):36-9.</citation>
    <PMID>373651</PMID>
  </reference>
  <reference>
    <citation>Jalava S, Saario R. Treatment of finger joints with local steroids. A double-blind study. Scand J Rheumatol. 1983;12(1):12-4.</citation>
    <PMID>6836233</PMID>
  </reference>
  <reference>
    <citation>Blyth T, Hunter JA, Stirling A. Pain relief in the rheumatoid knee after steroid injection. A single-blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide. Br J Rheumatol. 1994 May;33(5):461-3.</citation>
    <PMID>8173851</PMID>
  </reference>
  <reference>
    <citation>Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford). 2003 Oct;42(10):1254-9. Epub 2003 Jun 16.</citation>
    <PMID>12810938</PMID>
  </reference>
  <reference>
    <citation>McCarty DJ. Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide. Arthritis Rheum. 1972 Mar-Apr;15(2):157-73.</citation>
    <PMID>5027603</PMID>
  </reference>
  <reference>
    <citation>HOLLANDER JL, BROWN EM Jr, JESSAR RA, BROWN CY. Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc. 1951 Dec 22;147(17):1629-35.</citation>
    <PMID>14880415</PMID>
  </reference>
  <reference>
    <citation>Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24.</citation>
    <PMID>3358796</PMID>
  </reference>
  <reference>
    <citation>Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992 May;35(5):498-502.</citation>
    <PMID>1575785</PMID>
  </reference>
  <reference>
    <citation>Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995 Jun;38(6):727-35.</citation>
    <PMID>7779114</PMID>
  </reference>
  <reference>
    <citation>Ferraz MB, Quaresma MR, Aquino LR, Atra E, Tugwell P, Goldsmith CH. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol. 1990 Aug;17(8):1022-4.</citation>
    <PMID>2213777</PMID>
  </reference>
  <reference>
    <citation>Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol. 1997 Apr;24(4):779-81.</citation>
    <PMID>9101517</PMID>
  </reference>
  <reference>
    <citation>McCarty DJ, Harman JG, Grassanovich JL, Qian C. Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone hexacetonide. J Rheumatol. 1995 Sep;22(9):1631-5.</citation>
    <PMID>8523335</PMID>
  </reference>
  <reference>
    <citation>Srinivasan A, Amos M, Webley M. The effects of joint washout and steroid injection compared with either joint washout or steroid injection alone in rheumatoid knee effusion. Br J Rheumatol. 1995 Aug;34(8):771-3.</citation>
    <PMID>7551664</PMID>
  </reference>
  <reference>
    <citation>Armstrong RD, English J, Gibson T, Chakraborty J, Marks V. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis. 1981 Dec;40(6):571-4.</citation>
    <PMID>7332377</PMID>
  </reference>
  <reference>
    <citation>Steer JH, Ma DT, Dusci L, Garas G, Pedersen KE, Joyce DA. Altered leucocyte trafficking and suppressed tumour necrosis factor alpha release from peripheral blood monocytes after intra-articular glucocorticoid treatment. Ann Rheum Dis. 1998 Dec;57(12):732-7.</citation>
    <PMID>10070273</PMID>
  </reference>
  <reference>
    <citation>Weitoft T, Rönnblom L. Randomised controlled study of postinjection immobilisation after intra-articular glucocorticoid treatment for wrist synovitis. Ann Rheum Dis. 2003 Oct;62(10):1013-5.</citation>
    <PMID>12972485</PMID>
  </reference>
  <reference>
    <citation>Proudman SM, Conaghan PG, Richardson C, Griffiths B, Green MJ, McGonagle D, Wakefield RJ, Reece RJ, Miles S, Adebajo A, Gough A, Helliwell P, Martin M, Huston G, Pease C, Veale DJ, Isaacs J, van der Heijde DM, Emery P. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum. 2000 Aug;43(8):1809-19.</citation>
    <PMID>10943871</PMID>
  </reference>
  <reference>
    <citation>Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen A, Tarp U, Pødenphant J, Hansen G, Lindegaard H, de Carvalho A, Østergaard M, Hørslev-Petersen K; CIMESTRA Study Group. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum. 2006 May;54(5):1401-9.</citation>
    <PMID>16645967</PMID>
  </reference>
  <reference>
    <citation>American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002 Feb;46(2):328-46.</citation>
    <PMID>11840435</PMID>
  </reference>
  <reference>
    <citation>Intra-articular radioactive yttrium and triamcinolone hexacetonide: an inconclusive trial. Arthritis and Rheumatism Council Multicentre Radiosynoviorthesis Trial Group. Ann Rheum Dis. 1984 Aug;43(4):620-3.</citation>
    <PMID>6383234</PMID>
  </reference>
  <reference>
    <citation>Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2005 Feb;52(2):554-62.</citation>
    <PMID>15693001</PMID>
  </reference>
  <reference>
    <citation>Neidel J, Boehnke M, Küster RM. The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis. Arthritis Rheum. 2002 Jun;46(6):1620-8.</citation>
    <PMID>12115194</PMID>
  </reference>
  <reference>
    <citation>Schumacher HR, Chen LX. Injectable corticosteroids in treatment of arthritis of the knee. Am J Med. 2005 Nov;118(11):1208-14. Review.</citation>
    <PMID>16271901</PMID>
  </reference>
  <reference>
    <citation>Ostergaard M, Stoltenberg M, Gideon P, Sørensen K, Henriksen O, Lorenzen I. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol. 1996 Jul;23(7):1151-61.</citation>
    <PMID>8823685</PMID>
  </reference>
  <reference>
    <citation>Weitoft T, Larsson A, Saxne T, Rönnblom L. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis. Ann Rheum Dis. 2005 Dec;64(12):1750-3. Epub 2005 Apr 20.</citation>
    <PMID>15843449</PMID>
  </reference>
  <reference>
    <citation>Huppertz HI, Pfüller H. Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children. J Rheumatol. 1997 Sep;24(9):1833-7.</citation>
    <PMID>9292813</PMID>
  </reference>
  <reference>
    <citation>Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med. 1995 Jul 20;333(3):142-6.</citation>
    <PMID>7791815</PMID>
  </reference>
  <reference>
    <citation>Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol. 2000 Apr;16(4):505-11. Review.</citation>
    <PMID>10787466</PMID>
  </reference>
  <reference>
    <citation>Reid IR. Glucocorticoid-induced osteoporosis. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Jun;14(2):279-98. Review.</citation>
    <PMID>11035907</PMID>
  </reference>
  <reference>
    <citation>Furtado RN, Oliveira LM, Natour J. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study. J Rheumatol. 2005 Sep;32(9):1691-8.</citation>
    <PMID>16142862</PMID>
  </reference>
  <reference>
    <citation>Rausch-Stroomann JG, Petry R, Brandt T, Thomas E. [Comparative study on intramuscular and intraarticular administration of the depot steroid Triamcinolone acetonide]. Arzneimittelforschung. 1971 Jun;21(6):836-40. German.</citation>
    <PMID>5109272</PMID>
  </reference>
  <reference>
    <citation>Adebajo AO, Nash P, Hazleman BL. A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. J Rheumatol. 1990 Sep;17(9):1207-10.</citation>
    <PMID>2290163</PMID>
  </reference>
  <verification_date>July 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2007</study_first_submitted>
  <study_first_submitted_qc>July 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2007</study_first_posted>
  <last_update_submitted>July 20, 2007</last_update_submitted>
  <last_update_submitted_qc>July 20, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2007</last_update_posted>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>glucocorticoid</keyword>
  <keyword>intraarticular injection</keyword>
  <keyword>arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

